Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Syndax Pharmaceuticals (SNDX) Gross Margin: 2015-2020

Historic Gross Margin for Syndax Pharmaceuticals (SNDX) over the last 5 years, with Dec 2020 value amounting to 100.00%.

  • Syndax Pharmaceuticals' Gross Margin changed negligibly% to 100.00% in Q4 2020 from the same period last year, while for Dec 2020 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 96.51% for FY2024, which is 349.00% down from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Gross Margin stood at 100.00% for Q4 2020, which was down 0.00% from 100.00% recorded in Q3 2020.
  • Over the past 5 years, Syndax Pharmaceuticals' Gross Margin peaked at 100.00% during Q1 2016, and registered a low of 100.00% during Q1 2016.
  • In the last 3 years, Syndax Pharmaceuticals' Gross Margin had a median value of 100.00% in 2020 and averaged 100.00%.